Earlier today the chairman of Thorney Technologies Ltd (ASX: TEK), Alex Waislitz, released his quarterly update and revealed that the technology-focused investment company's performance over the last 12 months has been very strong.
As of the end of May, the company's net tangible assets (NTA) backing per share after fees was 30.7 cents per share, up from 29.7 cents per share a month earlier and 24.7 cents per share in the prior corresponding period.
This means that the company's NTA backing per share has increased by almost 25% on an annual basis.
Mr Waislitz revealed that this growth in NTA reflected the inherent strength of its portfolio and was the result of its relentless approach to due diligence and decision to work closely with the companies it decides to invest in.
Whilst the chairman didn't reveal all the shares that the company has been investing in, it did give away a few of the key contributors to its strong performance over the last 12 months. They are as follows:
Afterpay Touch Group (ASX: APT)
Afterpay Touch is of course the exciting tech company behind the Afterpay buy now, pay later platform. Its shares have rocketed an incredible 204% higher over the last 12 months thanks to its successful expansion into the massive U.S. market.
Credible Labs Inc (ASX: CRD)
Credible Labs is a loan comparison website operator which has seen its shares rise by 113% since this time last year. It has caught the eye this year thanks to strong growth in loan volumes. In the first quarter of FY 2019 the company reported an all-time high quarterly Closed Loan Volume (CLV) of US$440 million. This was up 127% on the prior corresponding period.
Dubber Corporation Limited (ASX: DUB)
The Dubber share price has been an impressive performer over the last 12 months, rising 211% over the period. This has been driven by strong demand for the Dubber Platform, which provides cloud-based call recording and audio asset management.
Next Science Limited (ASX: NXS)
This medical technology company's shares have risen a staggering 315% since hitting the ASX boards at $1.00 in April. Next Science has four FDA-cleared products currently available in the U.S. market to treat and manage surgical site infections and chronic wounds.
Zip Co Limited (ASX: Z1P)
The Zip Co share price is up a mouth-watering 303% over the last 12 months. The payment company's impressive first half result and equally strong third quarter result have been the catalysts for this rise. In the third quarter Zip Co posted a 20% increase in quarterly revenue to a record $23 million. It also added a further 143,000 customers to its platform, taking its total to a sizeable 1.2 million.
